ACADIA Pharmaceuticals Inc (ACAD)

48.00 -0.89  -1.82% NASDAQ Jun 2, 14:00 Delayed 2m USD

ACADIA Pharmaceuticals Total Assets (Quarterly):

747.45M for March 31, 2020
View 4,000+ financial data types
Browse...
View Full Chart

Total Assets (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Total Assets (Quarterly) Data

View and export this data going back to 2003. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2020 747.45M
Dec. 31, 2019 783.18M
Sept. 30, 2019 765.59M
June 30, 2019 460.88M
March 31, 2019 501.10M
Dec. 31, 2018 540.20M
Sept. 30, 2018 266.46M
June 30, 2018 314.96M
March 31, 2018 351.04M
Dec. 31, 2017 384.51M
Sept. 30, 2017 413.71M
June 30, 2017 456.32M
March 31, 2017 503.01M
Dec. 31, 2016 561.15M
Sept. 30, 2016 617.38M
June 30, 2016 438.03M
March 31, 2016 466.59M
Dec. 31, 2015 221.90M
Sept. 30, 2015 245.32M
June 30, 2015 275.54M
March 31, 2015 301.96M
Dec. 31, 2014 325.46M
Sept. 30, 2014 341.76M
June 30, 2014 359.46M
March 31, 2014 373.51M
   
Dec. 31, 2013 189.12M
Sept. 30, 2013 199.28M
June 30, 2013 206.91M
March 31, 2013 103.02M
Dec. 31, 2012 108.59M
Sept. 30, 2012 23.75M
June 30, 2012 21.87M
March 31, 2012 26.52M
Dec. 31, 2011 32.11M
Sept. 30, 2011 37.02M
June 30, 2011 41.31M
March 31, 2011 46.89M
Dec. 31, 2010 38.39M
Sept. 30, 2010 35.75M
June 30, 2010 39.17M
March 31, 2010 43.27M
Dec. 31, 2009 49.68M
Sept. 30, 2009 58.48M
June 30, 2009 70.06M
March 31, 2009 50.37M
Dec. 31, 2008 64.68M
Sept. 30, 2008 78.20M
June 30, 2008 96.08M
March 31, 2008 113.32M
Dec. 31, 2007 134.58M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Benchmarks

Benchmarks
Kodiak Sciences Inc 443.04M
Karyopharm Therapeutics Inc 416.14M
Alnylam Pharmaceuticals Inc 2.280B

Total Assets (Quarterly) Range, Past 5 Years

Minimum 221.90M Dec 2015
Maximum 783.18M Dec 2019
Average 465.72M
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.